Nitnib 12.5 Capsule
By Nitnib
Rx
7 Capsule in a Strip

Composition
Sunitinib(12.5mg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
October, 2025
About Nitnib 12.5 Capsule
Nitnib 12.5 Capsule is a medication primarily used to treat kidney cancer and gastrointestinal stromal tumor. The active ingredient in Nitnib 12.5 Capsule is sunitinib, classified as an 'antineoplastic agent'. This drug works by blocking specific enzymes that encourage the growth of cancer cells, ultimately leading to a reduction in tumor size and slowing down the progression of the disease.
Patients prescribed with Nitnib 12.5 Capsule are advised to take it regularly at the same time each day to maximize its benefits. The dosage and frequency of intake will be determined by the doctor based on the individual's condition and may vary over time. It is crucial to follow the doctor's instructions precisely to avoid serious side effects, such as weakness, diarrhea, nausea, vomiting, taste changes, and decreased appetite. It is important to note that it might take several weeks or months for the benefits of the medication to be noticeable, so patients should continue taking it unless advised otherwise by their doctor.
Individuals considering taking Nitnib 12.5 Capsule should inform their healthcare provider about any pre-existing conditions such as heart disease, liver or kidney problems, bleeding disorders, or if they are diabetic. Additionally, it is crucial to disclose all current medications to avoid potential interactions. Nitnib 12.5 Capsule is not recommended during pregnancy or breastfeeding, and effective contraception is advised during treatment to prevent pregnancy.
Common side effects of Nitnib 12.5 Capsule include weakness, diarrhea, nausea, vomiting, taste changes, and decreased appetite. Patients may also experience blood pressure and thyroid gland function fluctuations, which may necessitate regular monitoring. For diabetic patients, it is essential to monitor blood sugar levels regularly as the medication may lead to decreased levels. If any adverse reactions persist or worsen, it is crucial to inform the doctor promptly.
It is worth noting that Nitnib 12.5 Capsule should not be taken if allergic to any of its components. Caution should be exercised in patients with high blood pressure, heart issues, diabetes, liver or kidney problems, skin disorders, history of blood clots, or complications with the thyroid, pancreas, or gallbladder. The medication is not recommended for use in children and adolescents under 18 years of age. Patients are advised to avoid alcohol consumption as it may increase the risk of side effects. Due to the potential for dizziness, individuals should refrain from driving or operating heavy machinery if they are not fully alert.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹495
Inclusive of all taxes